HKD4.77
1.65%
Hong Kong, Sep 05, 10:08 am CET
ISIN
HK1093012172
Symbol
1093
Sector
Industry

CSPC Pharmaceutical Group Limited Stock price

HKD4.77
-1.07 18.32% 1M
-1.11 18.88% 6M
-2.49 34.30% YTD
-1.06 18.18% 1Y
-5.23 52.30% 3Y
-3.55 42.69% 5Y
+1.27 36.29% 10Y
Hong Kong, Closing price Fri, Sep 06 2024
+0.00 0.00%
ISIN
HK1093012172
Symbol
1093
Sector
Industry

Key metrics

Market capitalization HKD56.35b
Enterprise Value HKD46.88b
P/E (TTM) P/E ratio 8.81
EV/Sales (TTM) EV/Sales 1.37
P/S ratio (TTM) P/S ratio 1.65
P/B ratio (TTM) P/B ratio 1.55
Dividend yield 6.29%
Last dividend (FY23) HKD0.30
Revenue growth (TTM) Revenue growth -3.20%
Revenue (TTM) Revenue HKD34.25b
EBIT (operating result TTM) EBIT HKD7.67b
EPS (TTM) EPS HKD0.54
P/E forward 8.51
P/S forward 1.58
EV/Sales forward 1.32
Show more

Is CSPC Pharmaceutical Group Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

CSPC Pharmaceutical Group Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

19x Buy
70%
6x Hold
22%
2x Sell
7%

Analyst Opinions

27 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

Buy
70%
Hold
22%
Sell
7%

Financial data from CSPC Pharmaceutical Group Limited

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
34,250 34,250
3% 3%
100%
- Direct Costs 9,932 9,932
5% 5%
29%
24,319 24,319
3% 3%
71%
- Selling and Administrative Expenses 9,856 9,856
11% 11%
29%
- Research and Development Expense 5,484 5,484
10% 10%
16%
8,978 8,978
1% 1%
26%
- Depreciation and Amortization 1,313 1,313
6% 6%
4%
EBIT (Operating Income) EBIT 7,665 7,665
0% 0%
22%
Net Profit 6,413 6,413
7% 7%
19%

In millions HKD.

Don't miss a Thing! We will send you all news about CSPC Pharmaceutical Group Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.

Head office Hong Kong
CEO Cui Zhang
Employees 23,500
Founded 1997
Website www.cspc.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today